Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCORE2: Bevacizumab vs Aflibercept for CRVO
NCT01969708Phase 3Completed
- Sponsor
- Emmes
- Start
- Sep 2014
- Primary completion
- Nov 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in macular edema, sponsored by Emmes. Started Sep 2014; status: completed.
02
Drugs
bevacizumab
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT01969708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01969708.